Correlation Between Bank of America and Armata Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Bank of America and Armata Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank of America and Armata Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank of America and Armata Pharmaceuticals, you can compare the effects of market volatilities on Bank of America and Armata Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank of America with a short position of Armata Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank of America and Armata Pharmaceuticals.
Diversification Opportunities for Bank of America and Armata Pharmaceuticals
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Bank and Armata is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Bank of America and Armata Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Armata Pharmaceuticals and Bank of America is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank of America are associated (or correlated) with Armata Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Armata Pharmaceuticals has no effect on the direction of Bank of America i.e., Bank of America and Armata Pharmaceuticals go up and down completely randomly.
Pair Corralation between Bank of America and Armata Pharmaceuticals
Considering the 90-day investment horizon Bank of America is expected to generate 0.34 times more return on investment than Armata Pharmaceuticals. However, Bank of America is 2.9 times less risky than Armata Pharmaceuticals. It trades about 0.18 of its potential returns per unit of risk. Armata Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest 3,969 in Bank of America on August 28, 2024 and sell it today you would earn a total of 781.00 from holding Bank of America or generate 19.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bank of America vs. Armata Pharmaceuticals
Performance |
| Timeline |
| Bank of America |
| Armata Pharmaceuticals |
Bank of America and Armata Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bank of America and Armata Pharmaceuticals
The main advantage of trading using opposite Bank of America and Armata Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank of America position performs unexpectedly, Armata Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Armata Pharmaceuticals will offset losses from the drop in Armata Pharmaceuticals' long position.| Bank of America vs. Nu Holdings | Bank of America vs. HSBC Holdings PLC | Bank of America vs. Bank of Montreal | Bank of America vs. Bank of Nova |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |